Publication date: Available online 13 October 2026 Source: The Lancet Infectious Diseases Author(s): Leonie Mayer, Rolanda Londt, Eva Gruener, My Linh Ly, Marylyn M Addo, Christof Geldmacher
Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination. // The Lancet Infectious Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S1473309926005293?dgcid=rss_sd_all
Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination. The Lancet Infectious Diseases. https://www.sciencedirect.com/science/article/pii/S1473309926005293?dgcid=rss_sd_all
“Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination.” The Lancet Infectious Diseases.
@article{article90938,
title = {Cross-reactive T-cell responses against BDBV in humans after rVSVΔG-ZEBOV-GP vaccination},
journal = {The Lancet Infectious Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S1473309926005293?dgcid=rss_sd_all}
}
ABSTRACT Background Aspergillus fumigatus can cause life‐threatening infections, primarily treated with azole antifungals. Azole‐resistant A. fumigatus (ARAF) is a major clinical concern. Environmental resistance development is an...
ABSTRACT Background The lipid‐dependent yeast genus Malassezia is composed of skin commensals that can become pathogenic. This genus can cause bloodstream infection in low‐weight preterm neonates and immunocompromised adults. However,...